Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Genetics

Volumn 185, Issue 1, 2010, Pages 293-303

  Da Silva, Jack ^a   Coetzer, Mia ^b   Nedellec, Rebecca ^b   Pastore, Cristina ^b   Mosier, Donald E ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; VIRUS PROTEIN; CHEMOKINE RECEPTOR CCR5;

ADAPTATION; ARTICLE; EPISTASIS; GENE MUTATION; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS MUTANT; WILD TYPE; AMINO ACID SEQUENCE; CHEMISTRY; GENETIC EPISTASIS; GENETIC FITNESS; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; EPISTASIS, GENETIC; EVOLUTION, MOLECULAR; GENETIC FITNESS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 77956641491     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.109.112458     Document Type: Article

References (82)

1. ACHAZ, G., S. PALMER, M. KEARNEY, F. MALDARELLI, J. W. MELLORS et al., 2004 A robust measure of HIV-1 population turnover within chronically infected individuals. Mol. Biol. Evol. 21: 1902-1912.
2. BERSHTEIN, S., M. SEGAL, R. BEKERMAN, N. TOKURIKI and D. S. TAWFIK, 2006 Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444: 929-932.
3. BICKEL, P. J., P. C. COSMAN, R. A. OLSHEN, P. C. SPECTOR, A. G. RODRIGO et al., 1996 Covariability of V3 loop amino acids. AIDS Res. Hum. Retroviruses 12: 1401-1411.
4. BONHOEFFER, S., C. CHAPPEY, N. T. PARKIN, J. M. WHITCOMB and C. J. PETROPOULOS, 2004 Evidence for positive epistasis in HIV-1. Science 306: 1547-1550.
5. BURCH, C. L., and L. CHAO, 2000 Evolvability of an RNA virus is determined by its mutational neighbourhood. Nature 406: 625-628.
6. BURCH, C. L., and L. CHAO, 2004 Epistasis and its relationship to canalization in the RNA virus f6. Genetics 167: 559-567. (Pubitemid 38931847)
7. CARDOZO, T., T. KIMURA, S. PHILPOTT, B. WEISER, H. BURGER et al., 2007 Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res. Hum. Retroviruses 23: 415-426.
8. CHUN, T. W., L. CARRUTH, D. FINZI, X. SHEN, J. A. DIGIUSEPPE et al., 1997 Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
9. COETZER, M., R. NEDELLEC, J. SALKOWITZ, S. MCLAUGHLIN, Y. LIU et al., 2008 Evolution of CCR5 use before and during coreceptor switching. J. Virol. 82: 11758-11766.
10. COFFIN, J. M., 1999 Molecular biology of HIV, pp. 3-40 in The Evolution of HIV, edited by K. A. CRANDALL. The John Hopkins University Press, Baltimore.
11. CORMIER, E. G., and T. DRAGIC, 2002 The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76: 8953-8957.
12. DA SILVA, J., 2006 Site-specific amino acid frequency, fitness and the mutational landscape model of adaptation in human immunodeficiency virus type 1. Genetics 174: 1689-1694.
13. DAVIS, B. H., A. F. Y. POON and M. C. WHITLOCK, 2009 Compensatory mutations are repeatable and clustered within proteins. Proc. R. Soc. B. Biol. Sci. 276: 1823-1827.
14. DE JONG, J. J., A. DE RONDE, W. KEULEN, M. TERSMETTE and J. GOUDSMIT, 1992 Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66: 6777-6780.
15. DE VISSER, J. A. G. M., and S. F. ELENA, 2007 The evolution of sex: empirical insights into the roles of epistasis and drift. Nat. Rev. Genet. 8: 139-149.
16. DE VISSER, J. A. G. M., S. Ä. PARK and J. KRUG, 2009 Exploring the effect of sex on empirical fitness landscapes. Am. Nat. 174: S15-S30.
17. DEPRISTO, M. A., D. L. HARTL and D. M. WEINREICH, 2007 Mutational reversions during adaptive protein evolution. Mol. Biol. Evol. 24: 1608-1610.
18. DEPRISTO, M. A., D. M. WEINREICH and D. L. HARTL, 2005 Missense meanderings in sequence space: a biophysical view of protein evolution. Nat. Rev. Genet. 6: 678-687.
19. DITTMAR, M. T., A. MCKNIGHT, G. SIMMONS, P. R. CLAPHAM, R. A. WEISS et al., 1997 HIV-1 tropism and co-receptor use. Nature 385: 495-496.
20. EDINGER, A. L., T. L. HOFFMAN, M. SHARRON, B. LEE, B. O'DOWD et al., 1998 Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 249: 367-378.
21. FELSENSTEIN, J., 1988 Sex and the evolution of recombination, pp. 74-86 in The Evolution of Sex, edited by R. E. MICHOD and B. R. LEVIN. Sinauer Associates, Sunderland.
22. FISHER, R. A., 1930 The Genetical Theory of Natural Selection. Clarendon Press, Oxford.
23. FOUCHIER, R. A., M. GROENINK, N. A. KOOTSTRA, M. TERSMETTE, H. G. HUISMAN et al., 1992 Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66: 3183-3187.
24. GILLESPIE, J. H., 1984 Molecular evolution over the mutational landscape. Evolution 38: 1116-1129.
25. GOODMAN, L. A., 1962 The variance of the product of k random variables. J. Am. Statist. Assoc. 57: 54-60.
26. GORRY, P. R., R. L. DUNFEE, M. E. MEFFORD, K. KUNSTMAN, T. MORGAN et al., 2007 Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Δ32 heterozygote. Virology 362: 163-178.
27. HUANG, C.-C., S. N. LAM, P. ACHARYA, M. TANG, S.-H. XIANG et al., 2007 Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317: 1930-1934.
28. HUANG, C.-C., M. TANG, M.-Y. ZHANG, S. MAJEED, E. MONTABANA et al., 2005 Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-1028.
29. HUNG, C. S., N. VANDER HEYDEN and L. RATNER, 1999 Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 73: 8216-8226.
30. HWANG, S. S., T. J. BOYLE, H. K. LYERLY and B. R. CULLEN, 1991 Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253: 71-74.
31. JASNOS, L., and R. KORONA, 2007 Epistatic buffering of fitness loss in yeast double deletion strains. Nat. Genet. 39: 550-554.
32. JUNG, A., R. MAIER, J. P. VARTANIAN, G. BOCHAROV, V. JUNG et al., 2002 Multiply infected spleen cells in HIV patients. Nature 418: 144. (Pubitemid 34773761)
33. KIMURA, M., 1956 A model of a genetic system which leads to closer linkage by natural selection. Evolution 10: 278-287.
34. KONDRASHOV, A. S., 1993 Classification of hypotheses on the advantage of amphimixis. J. Hered. 84: 372-387.
35. KORBER, B. T., R. M. FARBER, D. H. WOLPERT and A. S. LAPEDES, 1993 Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc. Natl. Acad. Sci. USA 90: 7176-7180.
36. KOUYOS, R. D., C. L. ALTHAUS and S. BONHOEFFER, 2006 Stochastic or deterministic: What is the effective population size of HIV-1? Trends Microbiol. 14: 507-511.
37. KOUYOS, R. D., O. K. SILANDER and S. BONHOEFFER, 2007 Epistasis between deleterious mutations and the evolution of recombination. Trends Ecol. Evol. 22: 308-315.
38. KUIKEN, C., T. LEITNER, B. FOLEY, B. HAHN, P. MARX et al. (Editors), 2009 HIV Sequence Compendium 2009. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
39. LEIGH BROWN, A. J., 1997 Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94: 1862-1865.
40. LEVY, D. N., G. M. ALDROVANDI, O. KUTSCH and G. M. SHAW, 2004 Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA 101: 4204-4209.
41. LEWONTIN, R. C., and K.-I. KOJIMA, 1960 The evolutionary dynamics of complex polymorphisms. Evolution 14: 458-472.
42. LUNZER, M., S. P. MILLER, R. FELSHEIM and A. M. DEAN, 2005 The biochemical architecture of an ancient adaptive landscape. Science 310: 499-501.
43. MAISNIER-PATIN, S., and D. I. ANDERSSON, 2004 Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 155: 360-369.
44. MAISNIER-PATIN, S., J. R. ROTH, A. FREDRIKSSON, T. NYSTROM, O. G. BERG et al., 2005 Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nat. Genet. 37: 1376.
45. MAMMANO, F., V. TROUPLIN, V. ZENNOU and F. CLAVEL, 2000 Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J. Virol. 74: 8524-8531.
46. NIJHUIS, M., R. SCHUURMAN, D. D. JONG, J. ERICKSON, E. GUSTCHINA et al., 1999 Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13: 2349-2359.
47. OGERT, R. A., M. K. LEE, W. ROSS, A. BUCKLER-WHITE, M. A. MARTIN et al., 2001 N-Linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 75: 5998-6006.
48. ORTLUND, E. A., J. T. BRIDGHAM, M. R. REDINBO and J. W. THORNTON, 2007 Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317: 1544-1548.
49. PASTORE, C., R. NEDELLEC, A. RAMOS, O. HARTLEY, J. L. MIAMIDIAN et al., 2007 Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching. J. Virol. 81: 8165-8179.
50. PASTORE, C., R. NEDELLEC, A. RAMOS, S. PONTOW, L. RATNER et al., 2006 Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J. Virol. 80: 750-758.
51. PASTORE, C., A. RAMOS and D. E. MOSIER, 2004 Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. J. Virol. 78: 7565-7574.
52. PEPIN, K. M., and H. A. WICHMAN, 2007 Variable epistatic effects between mutations at host recognition sites in φX174 bacteriophage. Evolution 61: 1710-1724.
53. PHILLIPS, P. C., S. P. OTTO and M. C. WHITLOCK, 2000 Beyond the average: the evolutionary importance of gene interactions and variability of epistatic effects, pp. 20-38 in Epistasis and the Evolutionary Process, edited by J. B. WOLF, E. D. BRODIE and M. J. WADE. Oxford University Press, Oxford.
54. PHILPOTT, S. M., 2003 HIV-1 coreceptor usage, transmission, and disease progression. Curr. HIV Res. 1: 217-227.
55. PLATT, E. J., J. P. DURNIN and D. KABAT, 2005 Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J. Virol. 79: 4347-4356.
56. POLLAKIS, G., S. KANG, A. KLIPHUIS, M. I. CHALABY, J. GOUDSMIT et al., 2001 N-linked glycosylation of the HIV Type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 276: 13433-13441.
57. POON, A., and L. CHAO, 2005 The rate of compensatory mutation in the DNA bacteriophage ΦX174. Genetics 170: 989-999.
58. POON, A., B. H. DAVIS and L. CHAO, 2005 The coupon collector and the suppressor mutation: Estimating the number of compensatory mutations by maximum likelihood. Genetics 170: 1323-1332.
59. POON, A. F., and L. CHAO, 2006 Functional origins of fitness effect-sizes of compensatory mutations in the DNA bacteriophage φX174. Evolution 60: 2032-2043.
60. POON, A. F., F. I. LEWIS, S. L. POND and S. D. FROST, 2007 An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. PLoS Comput. Biol. 3: e231.
61. RICHMAN, D. D., T. WRIN, S. J. LITTLE and C. J. PETROPOULOS, 2003 Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100: 4144-4149.
62. ROSEN, O., M. SHARON, S. R. QUADT-AKABAYOV and J. ANGLISTER, 2006 Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion. Proc. Natl. Acad. Sci. USA 103: 13950-13955.
63. ROUZINE, I. M., and J. M. COFFIN, 1999 Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl. Acad. Sci. USA 96: 10758-10763.
64. SANJUAN, R., J. M. CUEVAS, A. MOYA and S. F. ELENA, 2005 Epistasis and the adaptability of an RNA virus. Genetics 170: 1001-1008.
65. SANJUAN, R., and S. F. ELENA, 2006 Epistasis correlates to genomic complexity. Proc. Natl. Acad. Sci. USA 103: 14402-14405.
66. SANJUAN, R., A. MOYA and S. F. ELENA, 2004 The contribution of epistasis to the architecture of fitness in an RNA virus. Proc. Natl. Acad. Sci. USA 101: 15376-15379.
67. SEO, T. K., J. L. THORNE, M. HASEGAWA and H. KISHINO, 2002 Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160: 1283-1293.
68. SHAPIRO, B., A. RAMBAUT, O. G. PYBUS and E. C. HOLMES, 2006 A phylogenetic method for detecting positive epistasis in gene sequences and its application to RNA virus evolution. Mol. Biol. Evol. 23: 1724-1730.
69. SHRINER, D., R. SHANKARAPPA, M. A. JENSEN, D. C. NICKLE, J. E. MITTLER et al., 2004 Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection. Genetics 166: 1155-1164.
70. SODA, Y., N. SHIMIZU, A. JINNO, H.-Y. LIU, K. KANBE et al., 1999 Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem. Biophys. Res. Commun. 258: 313-321.
71. SOKAL, R. R., and F. J. ROHLF, 1995 Biometry: The Principles and Practice of Statistics in Biological Research. Freeman, New York.
72. SPASSKY, B., T. DOBZHANSKY and W. W. ANDERSON, 1965 Genetics of natural populations. XXXVI. Epistatic interactions of the components of the genetic load in Drosophila pseudoobscura. Genetics 52: 653-664.
73. SPECK, R. F., K. WEHRLY, E. J. PLATT, R. E. ATCHISON, I. F. CHARO et al., 1997 Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71: 7136-7139.
74. TEMIN, R. G., H. U. MEYER, P. S. DAWSON and J. F. CROW, 1969 The influence of epistasis on homozygous viability depression in Drosophila melanogaster. Genetics 61: 497-519.
75. WEI, X., J. M. DECKER, S. WANG, H. HUI, J. C. KAPPES et al., 2003 Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
76. WEINREICH, D. M., and L. CHAO, 2005 Rapid evolutionary escape by large populations from local fitness peaks is likely in nature. Evolution 59: 1175-1182.
77. WEINREICH, D. M., N. F. DELANEY, M. A. DEPRISTO and D. L. HARTL, 2006 Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312: 111-114.
78. WEINREICH, D. M., R. A. WATSON and L. CHAO, 2005 Sign epistasis and genetic constraint on evolutionary trajectories. Evolution 59: 1165-1174.
79. WHITLOCK, M. C., P. C. PHILLIPS, F. B. MOORE and S. J. TONSOR, 1995 Multiple fitness peaks and epistasis. Ann. Rev. Ecol. Systematics 26: 601-629.
80. WRIGHT, S., 1932 The roles of mutation, inbreeding, crossbreeding and selection in evolution, pp. 356-366 in The Sixth International Congress of Genetics, edited by D. F. JONES. Brooklyn Botanic Garden, Menasha, WI.
81. WYATT, R., and J. SODROSKI, 1998 The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-1888.
82. ZOLLA-PAZNER, S., 2004 Identifying epitopes of HIV-1 that induce protective antibodies. Nat. Rev. Immunol. 4: 199-210.